Beta Bionics, Inc. (NASDAQ: BBNX) reported Q1 EPS of ($0.93), $0.51 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $17.6 million, versus $0 reported last year.

For earnings history and earnings-related data on Beta Bionics, Inc. (BBNX) click here.